Click here to receive MS news via e-mail
Biogen is a big pharmaceutical company that produces a half-dozen MS drugs. Among them are Tysabri, Avonex and Tecfidera. And Biogenis doing all it can to protect its turf, particularly when it comes to its best seller, Tecfidera.
Last month the company filed lawsuits against several pharmaceutical companies that are trying to develop generic versions of Tecfidera. According to an article in the Boston Business Journal, in the five days between June 26-30 Biogen filed 26 patent-infringement lawsuits in federal court against several competitors, including Mylan Pharmaceuticals and Sandoz.
The patents involved in the lawsuits expire over the next 10 years. In its suit against Sandoz, Biogen claims it “will suffer substantial and irreparable harm for which there is no adequate remedy at law” if the court allows a generic version of Tecfidera to be marketed right now.
MS Views and News is MAKING an IMPACT for those, affected by Multiple Sclerosis
MS Views and News provides beneficial Multiple Sclerosis education, information, resources and services.
Join us, opt-in here: www.register.msviewsandnews.org
…………………………
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews